Trial Site Detail


Imatinib, Nilotinib
REGISTER: A multicentre phase 2 study of risk evaluation in GIST with selective therapy escalation for response
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Ongoing, but not recruiting


Sydney Haematology and Oncology Clinics

49 Palmerston Road     Suite 13
Hornsby , New South Wales 2077


Principal Investigator:
Gavin Marx, MD
Activation Status of this Site:
Notes about this Site:
Sydney Haematology and Oncology Clinics Website:



Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.